Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Cooke

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
BJU International|April 12, 2002
Evaluation of the cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatmentP W Cooke
Physiologia Plantarum|January 1, 1984
Thigmomorphogenesis: on the mechanical properties of mechanically perturbed bean plantsM J Jaffe, F W Telewski, P W Cooke
BJU International|June 15, 1999
Patients' tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 casesM C Crundwell, P W Cooke, D M Wallace
The Journal of Pathology|July 9, 1999
CD40 expression in bladder cancerP W Cooke, N D James, R Ganesan, et al.
European Urology|August 15, 2000
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancerP W Cooke, J A Dunn, T Latief, et al.
BJU International|May 3, 2000
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapyP W Cooke, N D James, R Ganesan, et al.
Oncology Reports|April 10, 2003
BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladderS A Hussain, R Ganesan, L Hiller, et al.
Oncology Reports|September 18, 2004
CD40 expression in prostate cancer: a potential diagnostic and therapeutic moleculeD H Palmer, S A Hussain, R Ganesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2024
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)C C Parker, P M Petersen, A D Cook, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
BJU International|April 12, 2002
Evaluation of the cellular tumour rejection mechanisms in the peritumoral bladder wall after bacillus Calmette-Guérin treatmentP W Cooke
Physiologia Plantarum|January 1, 1984
Thigmomorphogenesis: on the mechanical properties of mechanically perturbed bean plantsM J Jaffe, F W Telewski, P W Cooke
BJU International|June 15, 1999
Patients' tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 casesM C Crundwell, P W Cooke, D M Wallace
The Journal of Pathology|July 9, 1999
CD40 expression in bladder cancerP W Cooke, N D James, R Ganesan, et al.
European Urology|August 15, 2000
Long-term risk of salvage cystectomy after radiotherapy for muscle-invasive bladder cancerP W Cooke, J A Dunn, T Latief, et al.
BJU International|May 3, 2000
Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapyP W Cooke, N D James, R Ganesan, et al.
Oncology Reports|April 10, 2003
BCL2 expression predicts survival in patients receiving synchronous chemoradiotherapy in advanced transitional cell carcinoma of the bladderS A Hussain, R Ganesan, L Hiller, et al.
Oncology Reports|September 18, 2004
CD40 expression in prostate cancer: a potential diagnostic and therapeutic moleculeD H Palmer, S A Hussain, R Ganesan, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 7, 2024
Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)C C Parker, P M Petersen, A D Cook, et al.
Pageof 1